Trials / Recruiting
RecruitingNCT03718637
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
Efficacy Evaluation of Surgical Treatment Using Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.
Detailed description
A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non surgery options for 6 months (physical therapy, lifestyle changes, anti-inflammatories, injections) Patients in the "control group" will receive the standard surgery (open lateral epicondylectomy) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Smith & Nephew Bioinductive Implant | A bioinductive implant that is supposed to foster healthy tendon regrowth after surgery. |
| PROCEDURE | Lateral Epicondylectomy | This procedure is the standard of care for lateral epicondylitis patients who fail conservative treatment options. |
| RADIATION | Ultrasound Imaging | An ultrasound will be performed on each patient both preoperatively and at 6 months. |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2026-05-17
- Completion
- 2027-01-17
- First posted
- 2018-10-24
- Last updated
- 2025-03-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03718637. Inclusion in this directory is not an endorsement.